Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Medicine (Baltimore) ; 100(7): e24634, 2021 Feb 19.
Article in English | MEDLINE | ID: mdl-33607799

ABSTRACT

INTRODUCTION: Fetal adenocarcinoma of the lung (FLAC) is an extremely rare tumor. Due to its rarity, most of the knowledge about FLAC comes from case reports. FLAC is an invasive adenocarcinoma that is similar to the fetal lung in the pseudo-glandular stage (8-16 weeks of gestation). Owing to the differences in histopathology and clinical process, FLAC has been further divided into low-level (L-FLAC) and high-level (H-FLAC). H-FLAC is usually associated with other conventional types of lung adenocarcinoma. Lung adenocarcinoma that produces alpha-fetoprotein (AFP) is a rare type of lung cancer. Its characteristics have not been fully elucidated. PATIENTS CONCERNS: We recently encountered this type of FLAC in a 51-year-old female patient. A computed tomography (CT) scan of the chest revealed a 74 × 51-mm sized tumor in the lingual segment of the superior lobe of the left lung. Among the tumor markers, serum AFP was elevated (816.2 ng/mL). PRIMARY DIAGNOSIS, INTERVENTIONS, AND OUTCOMES: The diagnosis of FLAC in this patient was confirmed by bronchoscopy with lung biopsy. Through a thoracoscope, left lung pneumonectomy, and mediastinal lymph node dissection were performed. The postoperative pathological results were consistent with the preoperative diagnosis of H-FLAC. Western blotting showed the difference in the AFP expression between the normal lung tissue and the cancerous lung tissue. Eventually, the diagnosis was AFP-producing H-FLAC. Using an immunohistochemical marker for AFP, cancer cells were shown to express AFP, specifically in their nuclei. After the operation, the patient underwent conventional chemotherapy. Her serum AFP gradually decreased over the course of 2 weeks. CONCLUSION: Presently, specific tumor markers for the diagnosis of lung cancer have not been established. To the best of our knowledge, this is the first case of abnormal AFP expression in a patient with H-FLAC. It may provide a basis for the clinical diagnosis of H-FLAC, a rare tumor, and AFP may be considered as a specific tumor marker.


Subject(s)
Adenocarcinoma of Lung/diagnostic imaging , Adenocarcinoma of Lung/pathology , alpha-Fetoproteins/metabolism , Biomarkers, Tumor/metabolism , Biopsy , Diagnosis, Differential , Female , Humans , Middle Aged , Neoplasm Grading , Neoplasm Staging
2.
Journal of Experimental Hematology ; (6): 1617-1621, 2019.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-775675

ABSTRACT

OBJECTIVE@#To investigate the curative effect of simply hormone and combined gamma globulin and thrombopoietin(TPO) on primary immune thrombocytopenia(PITP).@*METHODS@#100 patients with PITP were divided into simply drug groups, and combined drug group each for 50 cases. The patients in single drug group were given simply hormone therapy, the patients in combined drug group were given gamma globulin and thrombopoietin. The levels of TPO, platelet activating factor (PAF) were detected by DAS-ELISA. The differences of clinical curative effect, clinical indicators, biochemical indexes and adverse reactions between the two groups were compared.@*RESULTS@#The total effective rate of combined drug group (90.00%) was obviously higher than that in single drug group (66.00%)(P0.05), however, the above-mentioned indexes of two groups after treatment were lower than those before treatment (P0.05), the recurrence rate in combined drug group(2%) was obviously lower than that in single group(14.00%) (P<0.05).@*CONCLUSION@#The curative effect of hormone, as well as gamma globulin combined with TPO to treat PITP are satisfying, can obviously improve the levels of TPO, PAF, and the drug safety is higher. but the efficacy of combined drug is surperior to single drug.


Subject(s)
Humans , Immunoglobulins, Intravenous , Purpura, Thrombocytopenic, Idiopathic , Thrombopoietin , gamma-Globulins
SELECTION OF CITATIONS
SEARCH DETAIL
...